Iverkind 12 Tablet DT contains Ivermectin 12 mg, a broad-spectrum antiparasitic agent effective against a variety of parasitic infections. Ivermectin acts by binding selectively and with high affinity to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, leading to increased permeability to chloride ions, hyperpolarization, and subsequent paralysis and death of the parasite. This medication is primarily indicated for the treatment of onchocerciasis (river blindness), strongyloidiasis, and other nematode infections. Iverkind 12 Tablet DT is formulated as a dispersible tablet, facilitating ease of administration, especially in patients with swallowing difficulties. The drug demonstrates a favorable safety profile when used as directed, with adverse effects generally mild and transient, including dizziness, nausea, and rash. It is contraindicated in patients with known hypersensitivity to ivermectin or any component of the formulation. Caution is advised in patients with severe hepatic impairment or concomitant use of other neurotoxic drugs. Dosage should be individualized based on the indication and patient weight, and it is essential to follow the prescribed regimen to ensure optimal therapeutic outcomes. Iverkind 12 Tablet DT should be stored at room temperature, away from moisture and direct sunlight, and kept out of reach of children.